Skip to content
Offline

Halozyme Therapeutics Inc

🇩🇪XFRA.RV7GermanyHealthcare

€93.08EURup +1.08 (+1.17%)OpenEnd of day7:47 PM
OverviewAnalysisbetaPrice ChartFinancialsRevenue StreamsNot available for this exchange yetAnomaliesNewsNot available for this exchange yetInvestorsNot available for this exchange yetCorporate Actions

Price€93.08+1.08 (+1.17%)

Profile

  • Healthcare
  • Biotechnology
  • Germany

Identity

Exchange
Frankfurt Stock Exchange . XFRA
Type
Stock
ISIN
US40637H1095
CUSIP
Not reported

Company

Employees
423
Headquarters
San Diego, United States
Website
https://halozyme.com
CEO
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.

Market

Shares outstanding
117.6M
Market cap
€10.95B

Highlights

No high and low reported for today's session.

52-week range€52.50 - €96.60
from 252 sessions
Market cap
€10.95B
EPS LTM
$3.41
P/E LTM
22.66
Div yield
Not reported

Fundamentals (LTM)

Revenue
$1.66B+41.15%up year on year
Net income
$413.6M-25.78%down year on year
Gross margin
78.18%-3.7%down year on year
Free cash flow
$806.22M+49.11%up year on year

View all financials

Other listings

These are the venues Finzer covers, not every venue that exists.

Business summary

No company summary reported yet.

Cookies and analyticsWe measure how the site is used. Without your agreement we count you anonymously and store nothing on your device. Accept to let us link that to your account, so we can improve what you actually use. We never send personal data either way.We count visits anonymously. Accept to link them to your account. Privacy Policy